found semaglutide A new clinical trial supported by the National Institutes of Health (NIH) that a medication commonly used for weight loss, such as semaglutide, may also help reduce heavy drinking in individuals Retatrutide for weight loss: Study

Orforgliprons Edge: Non-Peptide Advantage in Pill Form Unlike peptide-based GLP-1s, orforglipron does not degrade in the stomach or require injection

GLP-1s can sometimes interfere with sleep patterns, so establishing excellent sleep hygiene is paramount

5563 About 40% patients with diabetes mellitus (diagnosed or not) have an advanced stage of kidney disease, often because of serious deficiencies in the management of the disease itself

Ozempic As a Future Employee Benefit Data shows many employees would change jobs to gain access to Ozempic and other GLP-1 medications

Transparency earned higher scores

Szpunar for her help in creating Table 2 and A